26-26-26-27-27-27-hexafluoro-1-25-dihydroxyvitamin-d3 has been researched along with paricalcitol* in 2 studies
2 review(s) available for 26-26-26-27-27-27-hexafluoro-1-25-dihydroxyvitamin-d3 and paricalcitol
| Article | Year |
|---|---|
Vitamin D receptor activators.
The fields for clinical employment of vitamin D analogs are growing and under active evaluation in different medical specialties, ranging from dermatology to immunology and oncology. In this review we provide a brief description of the drugs that have been developed more specifically for the treatment of secondary hyperparathyroidism (SH) associated with uremia. Topics: Calcitriol; Dihydroxycholecalciferols; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Uremia; Vitamin D | 2009 |
[The trend in the development of the active vitamin D3 and its analogues].
Topics: Calcitriol; Cholecalciferol; Drug Design; Ergocalciferols; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Vitamin D | 2004 |